Scientists have found that people who develop multiple sclerosis (MS) are more likely than others to have received a hepatitis B vaccination in recent years. Earlier studies investigating a link between the muscle-weakening disease and the vaccine had produced predominantly negative results.
“We were very surprised” by the new finding, says study coauthor Miguel A.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.